by The global Suture Needles market size is expected to be worth around US$ 840.9 million by 2030, according to a new report by Vision Research Reports.
The global Suture Needles market size was valued at US$ 479.8 million in 2020 and is anticipated to grow at a CAGR of 6.2% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39004
Growth Factors
In 2020, the COVID-19 pandemic stunted the market growth owing to the supply shortages of medical equipment because of temporary lockdowns of manufacturing sites in COVID-19-affected countries and travel restrictions affecting shipments.
The market growth is projected to be restrained by an increase in the number of suture needle injuries. Many healthcare professionals, particularly in super-specialized hospitals and tertiary care centers, have begun to use surgical staplers for suturing, which may act as a further restraint and lower the demand for suture needles.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 840.9 million by 2030 |
| Growth Rate | CAGR of 6.2% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Shape, Type, Application |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Medtronic; Futura Surgicare Pvt. Ltd.; Johnson & Johnson Medical N.V.; Aurolab; Natsume Seisakusho Co., Ltd.; Alfresa Pharma Corporation; Bear Medic Corporation; SUTUREX & RENODEX; Teleflex Incorporated; Smith & Nephew; Hu-Friedy Mfg. Co., LLC; FSSB Chirurgische Nadeln GmbH; Burtons Medical Equipment Ltd.; Advin Health Care |
By Shape Analysis
Straight-shaped needles accounted for the largest revenue share of over 40.0% in 2020. The segment growth can be linked to the increasing popularity of abdominal surgery and rhinoplasty.
The half-curved needle segment is expected to grow at a rapid pace over the forecast period. This is because a half-curved needle follows a predictable course through tissue and takes up less space than a straight needle.
By Type Analysis
Tapercut needle accounted for the largest revenue share of over 35.0% in 2020. The taper-point needle is used to puncture easily penetrated tissues (such as subcutaneous layers, dura, peritoneum, and abdominal viscera) while minimizing fascia tearing, which is anticipated to boost the demand for suture needles.
The blunt point needle segment is expected to grow at a rapid pace over the forecast period. Blunt point needle is recommended as an alternative to taper point needles as it significantly decreases the risk exposures during surgical procedures and can be used in place of traditional curved needles, which is projected to fuel the market expansion in the near future.
By Application Analysis
The cardiovascular segment accounted for the largest revenue share of over 35.0% in 2020. This is due to an increase in the frequency of cardiovascular diseases and technical breakthroughs in diagnosis, surgical equipment, and imaging.
The others segment includes gastrointestinal surgery, obstetrics surgery, urology, and oral surgery. This category is expected to grow significantly over the projected period due to an increase in the number of women’s health difficulties and an increase in the number of obese people.
By Regional Analysis
North America dominated the market with a revenue share of over 36.0% in 2020 owing to the high prevalence of cardiovascular illnesses and the high rate of adoption of minimally invasive treatments for cardiovascular and orthopedic diseases, which currently account for more than one-third of all deaths in the United States.
Asia Pacific is expected to expand at the highest CAGR of 6.8% from 2021 to 2030, owing to factors such as the introduction of technologically superior products as a result of market participants’ investments in the region, rising consumer disposable income, and a large volume of surgeries.
the Asia Pacific region’s major markets are China, Japan, and India. The important element driving the market in emerging countries is the increase in the number of surgical procedures and medical tourism. As a result, market growth is likely to accelerate in the near future.
Key Players
- Medtronic
- Futura Surgicare Pvt. Ltd.
- Johnson & Johnson Medical N.V.
- Aurolab
- Natsume Seisakusho Co., Ltd.
- Alfresa Pharma Corporation
- Bear Medic Corporation
- SUTUREX & RENODEX
- Teleflex Incorporated
- Smith & Nephew
- Hu-Friedy Mfg. Co., LLC
- FSSB Chirurgische Nadeln GmbH
- Burtons Medical Equipment Ltd.
- Advin Health Care
Market Segmentation
- By Shape
- Compound-cure Shaped Needles
- Straight Shaped Needles
- J Shape Needle
- Half Curved
- By Type
- Tapercut Needle
- Blunt Point Needle
- Reverse Cutting Needle
- Round Bodied Needle
- Conventional Cutting Needle
- Spatula Needle
- By Application
- Cardiovascular
- General Surgery
- Orthopedic Procedures
- Gynecological Procedures
- Veterinary Procedures
- Others
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Afghanistan
- New Zealand
- North Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Iran
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Suture Needles Market, By Shape
7.1. Suture Needles Market, by Shape, 2021-2030
7.1.1. Compound-cure Shaped Needles
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Straight Shaped Needles
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. J Shape Needle
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Half Curved
7.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Suture Needles Market, By Type
8.1. Suture Needles Market, by Type, 2021-2030
8.1.1. Tapercut Needle
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Blunt Point Needle
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Reverse Cutting Needle
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Round Bodied Needle
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Conventional Cutting Needle
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Spatula Needle
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Suture Needles Market, By Application
9.1. Suture Needles Market, by Application, 2021-2030
9.1.1. Cardiovascular
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. General Surgery
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Orthopedic Procedures
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Gynecological Procedures
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Veterinary Procedures
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Suture Needles Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Shape (2017-2030)
10.1.2. Market Revenue and Forecast, by Type (2017-2030)
10.1.3. Market Revenue and Forecast, by Application (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Shape (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Type (2017-2030)
10.1.4.3. Market Revenue and Forecast, by Application (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Shape (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Type (2017-2030)
10.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Shape (2017-2030)
10.2.2. Market Revenue and Forecast, by Type (2017-2030)
10.2.3. Market Revenue and Forecast, by Application (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Shape (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Type (2017-2030)
10.2.4.3. Market Revenue and Forecast, by Application (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Shape (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Type (2017-2030)
10.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Shape (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Type (2017-2030)
10.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Shape (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Type (2017-2030)
10.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Shape (2017-2030)
10.3.2. Market Revenue and Forecast, by Type (2017-2030)
10.3.3. Market Revenue and Forecast, by Application (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Shape (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Type (2017-2030)
10.3.4.3. Market Revenue and Forecast, by Application (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Shape (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Type (2017-2030)
10.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Shape (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Type (2017-2030)
10.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Shape (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Type (2017-2030)
10.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Shape (2017-2030)
10.4.2. Market Revenue and Forecast, by Type (2017-2030)
10.4.3. Market Revenue and Forecast, by Application (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Shape (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Type (2017-2030)
10.4.4.3. Market Revenue and Forecast, by Application (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Shape (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Type (2017-2030)
10.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Shape (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Type (2017-2030)
10.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Shape (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Type (2017-2030)
10.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Shape (2017-2030)
10.5.2. Market Revenue and Forecast, by Type (2017-2030)
10.5.3. Market Revenue and Forecast, by Application (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Shape (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Type (2017-2030)
10.5.4.3. Market Revenue and Forecast, by Application (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Shape (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Type (2017-2030)
10.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
Chapter 11. Company Profiles
11.1. Medtronic
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Futura Surgicare Pvt. Ltd.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Johnson & Johnson Medical N.V.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Aurolab
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Natsume Seisakusho Co., Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Alfresa Pharma Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Bear Medic Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. SUTUREX & RENODEX
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Teleflex Incorporated
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Smith & Nephew
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39004
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
